Quick Answer
Tenon Medical, Inc. reported Operating Income Loss of -$12.79 million for the year ending 2025.
- Tenon Medical, Inc. showed an increase of +7.1% in Operating Income Loss from 2024 to 2025.
- This data is from Tenon Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: -$189.0 thousand | Q2 2021: -$1.61 million | Q3 2021: -$2.10 million | Q1 2022: -$2.08 million | Q2 2022: -$5.46 million | Q3 2022: -$3.26 million | Q1 2023: -$4.89 million | Q2 2023: -$4.32 million | Q3 2023: -$3.38 million | Q1 2024: -$3.51 million | Q2 2024: -$3.87 million | Q3 2024: -$3.22 million | Q1 2025: -$3.68 million | Q2 2025: -$2.86 million | Q3 2025: -$3.39 million.
- Over the full 5 years of available data (2021 to 2025), Tenon Medical, Inc.'s Operating Income Loss has declined by 98.0%.
- Historical annual values: Fiscal year 2025: -$12.79 million | Fiscal year 2024: -$13.77 million | Fiscal year 2023: -$15.73 million | Fiscal year 2022: -$18.73 million | Fiscal year 2021: -$6.46 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: